Dicot Pharma AB
Developing next-gen potency drugs for erectile dysfunction and premature ejaculation.
DICOTBT | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0011178458 (+1 more)
- LEI:
- 549300GX132RSE4OV407
- Country:
- Sweden
- Address:
- St Olofsgatan 11A, 753 21 Uppsala
- Website:
- https://www.dicotpharma.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Dicot Pharma AB is a pharmaceutical company focused on developing the next generation of potency drugs. Its lead drug candidate, LIB-01, is in development for the treatment of erectile dysfunction and premature ejaculation. The company's objective is for LIB-01 to offer significant advantages over existing therapies, including a longer duration of effect, fewer side effects, and efficacy for a broader patient population. Dicot Pharma aims to establish LIB-01 as a first-choice treatment globally, addressing the needs of the over 500 million men worldwide affected by these conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Dicot Pharma AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Dicot Pharma AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-09-12 | Tullbacken Aktiebolag | Other | Buy | 35,000 | 40,250.00 SEK |
| 2024-09-10 | Amandus Jabin | Other | Sell | 110,000 | 4,276,800.00 SEK |
| 2024-09-03 | Jörgen Larsson | Other | Other | 315,000 | N/A |
| 2024-09-02 | Patrick Lawlor | Other | Buy | 77,500 | 1,158,625.00 SEK |
| 2024-09-02 | Oskar Hellström | Other | Buy | 75,000 | 1,121,250.00 SEK |
| 2024-09-02 | Martin Walfisz | Other | Other | 2,108,718 | 442,830.78 SEK |
| 2024-08-31 | Bonny Heeren | Other | Other | 5,000,000 | 550,000.00 SEK |
| 2024-08-30 | Per-Anders Hedin | Other | Other | 5,000,000 | 110,000.00 SEK |
| 2024-08-30 | Erik Markus Näsholm | Other | Other | 2,000,000 | 42,600.00 SEK |
| 2024-08-30 | Greger Larsson | Other | Other | 1,600,000 | 34,080.00 SEK |
